Observational Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Oct 16, 2023; 11(29): 7075-7081
Published online Oct 16, 2023. doi: 10.12998/wjcc.v11.i29.7075
Table 3 Comparison of the percentage of CD4+, CD8+ and T-regulatory cells across the different subgroups
Group
n
CD4+
CD8+
Tregs
Incipient 7932.67 ± 11.1139.26 ± 9.066.32 ± 3.21
Effectively treated 4528.63 ± 4.0738.59 ± 9.145.1 ± 2.02
Relapse-refractory 3438.01 ± 14.7640.15 ± 9.007.95 ± 3.76
Control 3026.15 ± 5.8437.14 ± 8.144.11 ± 2.26
F value9.439c0.67110.736c
P value< 0.0010.571< 0.001
Multiple comparisonThe proportion of CD4+ cells was higher in the incipient and relapsed-refractory groups than in the effectively treated and normal control groups./The proportion of Tregs was higher in the incipient and relapsed-refractory groups than in the effectively treated and normal control groups.